https://www.diabesityrounds.com/a/semaglutide-and-hba1c-weight-and-bp-across-ckd-stages-in-flow-post-hoc-analysisDiabesity Roundsen2026-11-04T20:32:59.680ZSemaglutide and HbA1c, weight and BP across CKD stages in FLOW post hoc analysishttps://www.diabesityrounds.com/a/weight-loss-not-significantly-linked-to-incretin-heart-benefit-in-meta-regressioDiabesity Roundsen2026-11-04T20:17:09.490ZWeight loss not significantly linked to incretin heart benefit in meta-regressionhttps://www.diabesityrounds.com/a/masld-found-in-64-9-of-1-103-adults-screened-with-fibroscan-in-chennaiDiabesity Roundsen2026-11-04T20:02:22.621ZMASLD found in 64.9% of 1,103 adults screened with FibroScan in Chennaihttps://www.diabesityrounds.com/a/real-world-cohort-sglt-2-inhibitors-linked-to-lower-kidney-failure-risk-than-glpDiabesity Roundsen2026-11-03T20:17:15.621ZReal-world cohort: SGLT-2 inhibitors linked to lower kidney failure risk than GLP-1 RAshttps://www.diabesityrounds.com/a/hypoglycaemia-linked-to-qtc-prolongation-in-type-1-and-type-2-diabetes-meta-analDiabesity Roundsen2026-11-03T20:02:09.742ZHypoglycaemia linked to QTc prolongation in type 1 and type 2 diabetes: meta-analysis